439 related articles for article (PubMed ID: 16780934)
1. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
[TBL] [Abstract][Full Text] [Related]
2. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
[TBL] [Abstract][Full Text] [Related]
3. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
Niu XY; Feng YK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
[TBL] [Abstract][Full Text] [Related]
4. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
5. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
[TBL] [Abstract][Full Text] [Related]
6. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
[TBL] [Abstract][Full Text] [Related]
7. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
Bogani G; DI Donato V; Sopracordevole F; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'Ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Tinelli R; DE Vincenzo R; Zannoni GF; Ferrandina G; Petrillo M; Dessole S; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
Gynecol Oncol; 2020 Dec; 159(3):636-641. PubMed ID: 32893030
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
[TBL] [Abstract][Full Text] [Related]
9. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
Houfflin Debarge V; Collinet P; Vinatier D; Ego A; Dewilde A; Boman F; Leroy JL
Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
[TBL] [Abstract][Full Text] [Related]
10. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
11. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y
Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
Ruano Y; Torrents M; Ferrer FJ
Eur J Gynaecol Oncol; 2015; 36(3):245-51. PubMed ID: 26189247
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
Kang WD; Kim SM
Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
15. Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.
Prato B; Ghelardi A; Gadducci A; Marchetti I; Di Cristofano C; Di Coscio G; Bevilacqua G; Genazzani AR
Int J Gynecol Cancer; 2008; 18(1):90-4. PubMed ID: 17506849
[TBL] [Abstract][Full Text] [Related]
16. A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3.
Kang WD; Ju UC; Kim SM
J Gynecol Oncol; 2016 Jan; 27(1):e2. PubMed ID: 26463431
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.
Jeong NH; Lee NW; Kim HJ; Kim T; Lee KW
J Obstet Gynaecol Res; 2009 Aug; 35(4):706-11. PubMed ID: 19751331
[TBL] [Abstract][Full Text] [Related]
18. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
[No Abstract] [Full Text] [Related]
19. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.
Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS
Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476
[TBL] [Abstract][Full Text] [Related]
20. Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia.
Aerssens A; Claeys P; Beerens E; Garcia A; Weyers S; Van Renterghem L; Praet M; Temmerman M; Velasquez R; Cuvelier CA
Cytopathology; 2009 Feb; 20(1):27-35. PubMed ID: 18510550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
